Insiders who reported open-market trades in the last 12 months at the companies Sanjiv Patel files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
Sanjiv Patel is a corporate insider, tracked as President and CEO, Director of Relay Therapeutics, Inc. (RLAY). InsiderAlpha holds 10 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Sanjiv Patel submitted recently?
3 primary Form 4 filings in the last 90 days, covering 1 company.
Has Sanjiv Patel been buying or selling stock?
Recorded transactions: 0 open-market purchases and 9 open-market sales ($5.20M) across all tracked filings.
Sanjiv Patel is President and CEO, Director of Relay Therapeutics, Inc. (RLAY). 10 SEC Form 4 filings on record going back to 2024, most recently on 8 October 2026. Most recent open-market trade: sold $872K of RLAY on 8 October 2026. Lifetime open-market sales: $5.20M.
Recent transactions
12
The latest 12 SEC Form 4 transactions reported by Sanjiv Patel.
InsiderAlpha's records for Sanjiv Patel go back to 2024: 10 primary Form 4 filings, an average of 3.3 per year. 6 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
